Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
Sex drive and sexual desire.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
Production, crystallization and neutron diffraction of fully deuterated human myelin peripheral membrane protein P2.
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Bridging network divides: Building capacity to support aging with disability populations through research.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.

Pages